Biomarker Intelligence 5 min read
HOMA-IR: Detecting Insulin Resistance Before Diabetes
Dr. R. Brahmananda Reddy
6 April 2026
Knowledge Hub
Dr. R. Brahmananda Reddy
6 April 2026
Type 2 diabetes does not appear overnight. It is the end stage of a metabolic process that begins 10 to 15 years earlier with a condition called insulin resistance. During this long prologue, your blood sugar may remain perfectly normal on standard tests — because your pancreas is working overtime, pumping out ever-increasing amounts of insulin to compensate.
This is the metabolic equivalent of a swan gliding serenely on a lake while paddling furiously beneath the surface. Everything looks fine — until the pancreas can no longer keep up.
HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. It is calculated from two simple blood tests: fasting glucose and fasting insulin. The formula multiplies fasting glucose (mg/dL) by fasting insulin (μIU/mL) and divides by 405.
What makes HOMA-IR powerful is that it captures the relationship between glucose and insulin — not just the glucose alone. A fasting glucose of 90 mg/dL with a fasting insulin of 5 μIU/mL tells a very different story than the same glucose with a fasting insulin of 18 μIU/mL. In the second scenario, your body is shouting for help, but your glucose report says everything is fine.
Conventional medicine considers HOMA-IR below 2.5 as normal. But longevity-focused practitioners aim for tighter targets:
Below 1.0: Optimal insulin sensitivity. Your cells are responding efficiently to insulin signals.
1.0-1.5: Acceptable but worth monitoring. Early lifestyle intervention can prevent progression.
1.5-2.5: Early insulin resistance. Active intervention is strongly recommended even though your glucose is probably still "normal."
Above 2.5: Significant insulin resistance. Without intervention, progression to prediabetes and diabetes is likely.
India faces a unique metabolic challenge. Due to genetic predisposition, body composition patterns (higher visceral fat at lower BMIs), and dietary factors, Indians develop insulin resistance at lower body weights and younger ages than Western populations. A 2020 study in The Lancet Diabetes & Endocrinology estimated that India has over 77 million adults with diabetes and an even larger number with undiagnosed insulin resistance.
Standard glucose testing misses the majority of these individuals. HOMA-IR catches them years — sometimes a full decade — earlier.
The encouraging news is that insulin resistance is highly responsive to intervention, especially when caught early. Structured exercise (both aerobic and resistance training), reduction in refined carbohydrates, time-restricted eating, adequate sleep, and stress management can dramatically improve HOMA-IR within weeks to months.
A 2021 clinical trial demonstrated that a 12-week lifestyle intervention combining moderate exercise with dietary modification reduced HOMA-IR by an average of 40% in participants with early insulin resistance.
At GenoRyx, we consider HOMA-IR an essential component of metabolic health assessment. If your annual checkup includes only fasting glucose and HbA1c, you may be missing the earliest — and most reversible — stage of metabolic dysfunction. Schedule a consultation and let us look beneath the surface of your blood sugar numbers.
Book your 400+ biomarker assessment — physician consultation included.
Schedule a consultationReady to know your numbers?
Schedule your consultation with our longevity physician team.
Book Your AssessmentWritten by
UK-trained physician and founder of Genoryx. Writes about longevity medicine, healthspan optimization, and evidence-based wellness.
View profile →
Learn why wearable VO2 Max data can be misleading. Discover how clinical VO2 Max testing in Hyderabad provides precision data for longevity and performance.
Your Apple Watch tracks your heart rate continuously. Your blood test measures it once a year. Both data streams have value, but neither tells the complete story alone.
